Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Digital

Autores:

Gerstein, Hertzel C.
Colhoun, Helen M.
Dagenais, Gilles R.
Diaz, Rafael
Lakshmanan, Mark
Pais, Prem
Probstfield, Jeffrey
Riesmeyer, Jeffrey S.
Riddle, Matthew C.
Rydén, Lars
Xavier, Denis
Messan Atisso, Charles
Dyal, Leanne
Hall, Stephanie
Rao-Melacini, Purnima
Wong, Gloria
Avezum, Alvaro
Basile, Jan
Chung, Namsik
Conget, Ignacio
Cushman, William C.
Franek, Edward
Hancu, Nicolae
Hanefeld, Markolf
Holt, Shaun
Jansky, Petr
Keltai, Matyas Matyas
Lanas, Fernando
Leiter, Lawrence A.
Lopez-Jaramillo, Patricio
Cardona-Munoz, Ernesto German
Pirags, Valdis
Pogosova, Nana
Raubenheimer, Peter J.
Shaw, Jonathan E.
Sheu, Wayne H-H.
Temelkova-Kurktschiev, Theodora
The REWIND Investigators

Tipo de recurso:

Article of journal

Fecha de publicación:

2019

Institución:

Universidad de Santander

Repositorio:

Repositorio Universidad de Santander

Idioma:

eng

OAI Identifier:

oai:repositorio.udes.edu.co:001/5694

Acceso en línea:

https://doi.org/10.1016/S0140-6736(19)31149-3
https://repositorio.udes.edu.co/handle/001/5694

Palabra clave:

Rights

closedAccess

License

Copyright © 2019 Elsevier Ltd. All rights reserved.